AURORA CANNABIS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.9 EUR | -20.00% |
|
-0.79% | +55.18% |
| Sales 2024 * | 272M 198M 185M | Sales 2025 * | 320M 233M 218M | Capitalization | 552M 403M 376M |
|---|---|---|---|---|---|
| Net income 2024 * | -61M -44.46M -41.57M | Net income 2025 * | -7M -5.1M -4.77M | EV / Sales 2024 * | 2.03 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.73 x |
| P/E ratio 2024 * |
-6.47
x | P/E ratio 2025 * |
-62.3
x | Employees | 1,130 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
Latest transcript on Aurora Cannabis Inc.
More recommendations
More press releases
| 1 day | -20.00% | ||
| 1 week | -0.79% | ||
| Current month | +68.45% | ||
| 1 month | +41.89% | ||
| 3 months | +86.76% | ||
| 6 months | +65.19% | ||
| Current year | +55.18% |
1 week
5.76
7.23
1 month
4.108.12
Current year
0.348.12
1 year
0.3410.79
3 years
0.3486.91
5 years
0.34972.36
10 years
0.341 324.80
| Managers | Title | Age | Since |
|---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 20-07-05 |
Simona King
DFI | Director of Finance/CFO | 52 | Feb. 20 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 18-07-24 |
Michael Singer
BRD | Director/Board Member | 60 | 16-05-19 |
Adam Szweras
BRD | Director/Board Member | 52 | 15-08-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 6.91 | -19.88% | 22 327 |
| 24-04-30 | 8.625 | +44.23% | 43,148 |
| 24-04-29 | 5.98 | -4.63% | 3,852 |
| 24-04-26 | 6.27 | -0.08% | 28,085 |
| 24-04-25 | 6.275 | -6.34% | 18,056 |
Delayed Quote Deutsche Boerse AG, May 02, 2024 at 08:09 am EDT
More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
10.13
CAD
Average target price
9.681
CAD
Spread / Average Target
-4.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +39.33% | 6.11B | |
| -18.38% | 4.35B | |
| -9.17% | 3.18B | |
| +3.98% | 3.16B | |
| -3.41% | 2.51B | |
| +48.74% | 1.98B | |
| -4.82% | 1.74B | |
| -1.24% | 1.63B | |
| -8.96% | 1.6B |
- Stock Market
- Equities
- ACB Stock
- 21P Stock
